Von Willebrand Factor A Domain Containing 5A (VWA5A) Peptid
VWA5A
Reaktivität: Human, Maus, Affe, Ratte
Wirt: Synthetic
BP
-
- Target Alle VWA5A Produkte
- VWA5A (Von Willebrand Factor A Domain Containing 5A (VWA5A))
- Spezies
- Human, Maus, Affe, Ratte
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP)
- Produktmerkmale
- The peptide is used to block Anti-VWA5A Antibody reactivity.
-
-
- Applikationshinweise
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year.
- Haltbarkeit
- 12 months
-
- Target
- VWA5A (Von Willebrand Factor A Domain Containing 5A (VWA5A))
- Synonyme
- VWA5A Peptide, LOH11CR2A Peptide, MGC68953 Peptide, loh11cr2a Peptide, BCSC-1 Peptide, BCSC1 Peptide, 5830475I06Rik Peptide, AW552491 Peptide, E130119J22 Peptide, Loh11cr2a Peptide, masa-1 Peptide, loss of heterozygosity, 11, chromosomal region 2, gene A Peptide, von Willebrand factor A domain containing 5A Peptide, von Willebrand factor A domain containing 5A S homeolog Peptide, LOH11CR2A Peptide, VWA5A Peptide, vwa5a.S Peptide, vwa5a Peptide, Vwa5a Peptide
- Hintergrund
- BCSC1, LOH11CR2A, von Willebrand factor A domain-containing protein 5A, Breast cancer suppressor candidate 1, BCSC-1, Loss of heterozygosity 11 chromosomal region 2 gene A protein
- Gen-ID
- 4013, 67776
- UniProt
- O00534, Q99KC8
-
Sie sind hier:
